{"entity":{"type":"insider","cik":"0001594914","url":"/insider/0001594914","json_url":"/insider/0001594914.json","name":"Foresite Capital Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":16,"first":"2015-08-11","last":"2020-05-14","span_basis":"filed_date"},"name_variants":[{"name":"Foresite Capital Fund II, L.P.","source":"filing","n_filings":16,"first_seen":"2015-08-11","last_seen":"2020-05-14"}],"transactions":[{"id":2039810,"accession":"0000899243-20-013113","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-013113","line_url":"/filing/0000899243-20-013113#line-3","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management I, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund I, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":80.13,"price_display":"80.13","price_state":"stated","total_value":64104000.0,"total_display":"64,104,000.00","shares_owned_after":3500000.0,"shares_owned_after_display":"3,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-14","scope":"insider"},{"id":2039808,"accession":"0000899243-20-013113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-013113","line_url":"/filing/0000899243-20-013113#line-2","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management I, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund I, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650000.0,"shares_display":"650,000","price_per_share":80.13,"price_display":"80.13","price_state":"stated","total_value":52084500.0,"total_display":"52,084,500.00","shares_owned_after":2350000.0,"shares_owned_after_display":"2,350,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-14","scope":"insider"},{"id":2244463,"accession":"0000899243-20-009021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-009021","line_url":"/filing/0000899243-20-009021#line-4","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":29500000.0,"total_display":"29,500,000.00","shares_owned_after":1134579.0,"shares_owned_after_display":"1,134,579","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":2244460,"accession":"0000899243-20-009021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-009021","line_url":"/filing/0000899243-20-009021#line-3","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":14750000.0,"total_display":"14,750,000.00","shares_owned_after":433725.0,"shares_owned_after_display":"433,725","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":2138464,"accession":"0001209191-20-014562","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-014562","line_url":"/filing/0001209191-20-014562#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":425457.0,"shares_display":"425,457","price_per_share":17.07,"price_display":"17.07","price_state":"stated","total_value":7262550.99,"total_display":"7,262,550.99","shares_owned_after":1925020.0,"shares_owned_after_display":"1,925,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":2138462,"accession":"0001209191-20-014562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-014562","line_url":"/filing/0001209191-20-014562#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302776.0,"shares_display":"302,776","price_per_share":17.07,"price_display":"17.07","price_state":"stated","total_value":5168386.32,"total_display":"5,168,386.32","shares_owned_after":1369938.0,"shares_owned_after_display":"1,369,938","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":2138459,"accession":"0001209191-20-014562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-014562","line_url":"/filing/0001209191-20-014562#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":271767.0,"shares_display":"271,767","price_per_share":17.07,"price_display":"17.07","price_state":"stated","total_value":4639062.69,"total_display":"4,639,062.69","shares_owned_after":1229633.0,"shares_owned_after_display":"1,229,633","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":8647388,"accession":"0001209191-19-049680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049680","line_url":"/filing/0001209191-19-049680#line-1","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Foresite Capital Management I, LLC; Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":39.0,"price_display":"39.00","price_state":"stated","total_value":7312500.0,"total_display":"7,312,500.00","shares_owned_after":187500.0,"shares_owned_after_display":"187,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-16","scope":"insider"},{"id":8120795,"accession":"0001209191-19-048830","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-048830","line_url":"/filing/0001209191-19-048830#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15700.0,"shares_display":"15,700","price_per_share":18.42,"price_display":"18.42","price_state":"stated","total_value":289194.0,"total_display":"289,194.00","shares_owned_after":2350477.0,"shares_owned_after_display":"2,350,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-05","filed_date":"2019-09-06","scope":"insider"},{"id":8120792,"accession":"0001209191-19-048830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-048830","line_url":"/filing/0001209191-19-048830#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90900.0,"shares_display":"90,900","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":1679832.0,"total_display":"1,679,832.00","shares_owned_after":1400900.0,"shares_owned_after_display":"1,400,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider"},{"id":8120788,"accession":"0001209191-19-048830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-048830","line_url":"/filing/0001209191-19-048830#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9300.0,"shares_display":"9,300","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":171864.0,"total_display":"171,864.00","shares_owned_after":2334777.0,"shares_owned_after_display":"2,334,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider"},{"id":8102225,"accession":"0001209191-19-048394","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-048394","line_url":"/filing/0001209191-19-048394#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34900.0,"shares_display":"34,900","price_per_share":20.54,"price_display":"20.54","price_state":"stated","total_value":716846.0,"total_display":"716,846.00","shares_owned_after":2310377.0,"shares_owned_after_display":"2,310,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-04","scope":"insider"},{"id":8102217,"accession":"0001209191-19-048394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-048394","line_url":"/filing/0001209191-19-048394#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15100.0,"shares_display":"15,100","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":323895.0,"total_display":"323,895.00","shares_owned_after":2325477.0,"shares_owned_after_display":"2,325,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-04","scope":"insider"},{"id":8102213,"accession":"0001209191-19-048394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-048394","line_url":"/filing/0001209191-19-048394#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":21.36,"price_display":"21.36","price_state":"stated","total_value":534000.0,"total_display":"534,000.00","shares_owned_after":2275477.0,"shares_owned_after_display":"2,275,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-04","scope":"insider"},{"id":8027908,"accession":"0001209191-19-047387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047387","line_url":"/filing/0001209191-19-047387#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38300.0,"shares_display":"38,300","price_per_share":23.42,"price_display":"23.42","price_state":"stated","total_value":896986.0,"total_display":"896,986.00","shares_owned_after":2250477.0,"shares_owned_after_display":"2,250,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-23","scope":"insider"},{"id":8027907,"accession":"0001209191-19-047387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047387","line_url":"/filing/0001209191-19-047387#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6700.0,"shares_display":"6,700","price_per_share":23.68,"price_display":"23.68","price_state":"stated","total_value":158656.0,"total_display":"158,656.00","shares_owned_after":2212177.0,"shares_owned_after_display":"2,212,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-23","scope":"insider"},{"id":8027902,"accession":"0001209191-19-047387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047387","line_url":"/filing/0001209191-19-047387#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1153.0,"shares_display":"1,153","price_per_share":23.25,"price_display":"23.25","price_state":"stated","total_value":26807.25,"total_display":"26,807.25","shares_owned_after":2205477.0,"shares_owned_after_display":"2,205,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-23","scope":"insider"},{"id":8120433,"accession":"0001209191-19-046913","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-046913","line_url":"/filing/0001209191-19-046913#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":23.21,"price_display":"23.21","price_state":"stated","total_value":1160500.0,"total_display":"1,160,500.00","shares_owned_after":2204324.0,"shares_owned_after_display":"2,204,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":8120430,"accession":"0001209191-19-046913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046913","line_url":"/filing/0001209191-19-046913#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3847.0,"shares_display":"3,847","price_per_share":23.34,"price_display":"23.34","price_state":"stated","total_value":89788.98,"total_display":"89,788.98","shares_owned_after":2154324.0,"shares_owned_after_display":"2,154,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-20","scope":"insider"},{"id":8120427,"accession":"0001209191-19-046913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046913","line_url":"/filing/0001209191-19-046913#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Fund IV, L.P.; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":24.23,"price_display":"24.23","price_state":"stated","total_value":2423000.0,"total_display":"2,423,000.00","shares_owned_after":2150477.0,"shares_owned_after_display":"2,150,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-20","scope":"insider"},{"id":8568332,"accession":"0001209191-19-046012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-046012","line_url":"/filing/0001209191-19-046012#line-4","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":23.73,"price_display":"23.73","price_state":"stated","total_value":2373000.0,"total_display":"2,373,000.00","shares_owned_after":2050477.0,"shares_owned_after_display":"2,050,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-14","scope":"insider"},{"id":8568328,"accession":"0001209191-19-046012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-046012","line_url":"/filing/0001209191-19-046012#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":178903.0,"shares_display":"178,903","price_per_share":25.52,"price_display":"25.52","price_state":"stated","total_value":4565604.56,"total_display":"4,565,604.56","shares_owned_after":1310000.0,"shares_owned_after_display":"1,310,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":8568325,"accession":"0001209191-19-046012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046012","line_url":"/filing/0001209191-19-046012#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71097.0,"shares_display":"71,097","price_per_share":24.92,"price_display":"24.92","price_state":"stated","total_value":1771737.24,"total_display":"1,771,737.24","shares_owned_after":1131097.0,"shares_owned_after_display":"1,131,097","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":8568322,"accession":"0001209191-19-046012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046012","line_url":"/filing/0001209191-19-046012#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund IV, L.P.; Foresite Capital Management III, LLC; Foresite Capital Management IV, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":189555.0,"shares_display":"189,555","price_per_share":24.43,"price_display":"24.43","price_state":"stated","total_value":4630828.65,"total_display":"4,630,828.65","shares_owned_after":1060000.0,"shares_owned_after_display":"1,060,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider"},{"id":4197054,"accession":"0001209191-17-036603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-036603","line_url":"/filing/0001209191-17-036603#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10182.0,"shares_display":"10,182","price_per_share":55.95,"price_display":"55.95","price_state":"stated","total_value":569682.9,"total_display":"569,682.90","shares_owned_after":1950477.0,"shares_owned_after_display":"1,950,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-26","filed_date":"2017-05-31","scope":"insider"},{"id":4197052,"accession":"0001209191-17-036603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-036603","line_url":"/filing/0001209191-17-036603#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9818.0,"shares_display":"9,818","price_per_share":55.95,"price_display":"55.95","price_state":"stated","total_value":549317.1,"total_display":"549,317.10","shares_owned_after":1672714.0,"shares_owned_after_display":"1,672,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-26","filed_date":"2017-05-31","scope":"insider"},{"id":9270141,"accession":"0001209191-16-145532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-145532","line_url":"/filing/0001209191-16-145532#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Management III, LLC; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24813.0,"shares_display":"24,813","price_per_share":40.3399,"price_display":"40.34","price_state":"stated","total_value":1000953.9387,"total_display":"1,000,953.94","shares_owned_after":1647901.0,"shares_owned_after_display":"1,647,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-11","scope":"insider"},{"id":9270140,"accession":"0001209191-16-145532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-145532","line_url":"/filing/0001209191-16-145532#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Management III, LLC; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25187.0,"shares_display":"25,187","price_per_share":40.3399,"price_display":"40.34","price_state":"stated","total_value":1016041.0613,"total_display":"1,016,041.06","shares_owned_after":1672697.0,"shares_owned_after_display":"1,672,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-11","scope":"insider"},{"id":2421758,"accession":"0001209191-16-145487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-145487","line_url":"/filing/0001209191-16-145487#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25187.0,"shares_display":"25,187","price_per_share":40.3399,"price_display":"40.34","price_state":"stated","total_value":1016041.0613,"total_display":"1,016,041.06","shares_owned_after":1672697.0,"shares_owned_after_display":"1,672,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-07","scope":"insider"},{"id":2421755,"accession":"0001209191-16-145487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-145487","line_url":"/filing/0001209191-16-145487#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24813.0,"shares_display":"24,813","price_per_share":40.3399,"price_display":"40.34","price_state":"stated","total_value":1000953.9387,"total_display":"1,000,953.94","shares_owned_after":1647901.0,"shares_owned_after_display":"1,647,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-07","scope":"insider"},{"id":2130890,"accession":"0001209191-16-133904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-133904","line_url":"/filing/0001209191-16-133904#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Tananbaum James B.; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":4375000.0,"total_display":"4,375,000.00","shares_owned_after":1697884.0,"shares_owned_after_display":"1,697,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-22","filed_date":"2016-07-26","scope":"insider"},{"id":2414185,"accession":"0001209191-16-125229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-125229","line_url":"/filing/0001209191-16-125229#line-2","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Management II, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC; Foresite Capital Fund II, L.P.; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":15.228,"price_display":"15.23","price_state":"stated","total_value":1827360.0,"total_display":"1,827,360.00","shares_owned_after":3967900.0,"shares_owned_after_display":"3,967,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":2414178,"accession":"0001209191-16-125229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-125229","line_url":"/filing/0001209191-16-125229#line-1","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Management II, LLC; Foresite Capital Fund III, L.P.; Foresite Capital Management III, LLC; Foresite Capital Fund II, L.P.; Tananbaum James B.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":15.228,"price_display":"15.23","price_state":"stated","total_value":1827360.0,"total_display":"1,827,360.00","shares_owned_after":235020.0,"shares_owned_after_display":"235,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":8848692,"accession":"0001209191-15-068040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-068040","line_url":"/filing/0001209191-15-068040#line-1","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Tananbaum James B.; Foresite Capital Fund III, L.P.; Foresite Capital Management II, LLC; Foresite Capital Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25485.0,"shares_display":"25,485","price_per_share":19.6547,"price_display":"19.65","price_state":"stated","total_value":500900.0295,"total_display":"500,900.03","shares_owned_after":355020.0,"shares_owned_after_display":"355,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-24","filed_date":"2015-08-26","scope":"insider"},{"id":8391485,"accession":"0000899243-15-002782","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-15-002782","line_url":"/filing/0000899243-15-002782#line-4","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":4087900.0,"shares_owned_after_display":"4,087,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"},{"id":8391481,"accession":"0000899243-15-002782","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-002782","line_url":"/filing/0000899243-15-002782#line-3","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":312500.0,"shares_owned_after_display":"312,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"},{"id":8391477,"accession":"0000899243-15-002782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-002782","line_url":"/filing/0000899243-15-002782#line-2","is_derivative":false,"issuer_cik":"0001581754","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001581754","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Tananbaum James B.; Foresite Capital Management III, LLC; Foresite Capital Management II, LLC; Foresite Capital Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17035.0,"shares_display":"17,035","price_per_share":20.4989,"price_display":"20.50","price_state":"stated","total_value":349198.7615,"total_display":"349,198.76","shares_owned_after":329535.0,"shares_owned_after_display":"329,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770787","name":"10x Genomics, Inc.","url":"/issuer/0001770787","role":"Ten percent owner","n_filings":3,"first_seen":"2019-09-16","last_seen":"2020-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Ten percent owner","n_filings":10,"first_seen":"2016-07-26","last_seen":"2020-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Ten percent owner","n_filings":3,"first_seen":"2015-08-11","last_seen":"2016-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001594914","retrieved_at":"2026-08-21T02:04:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}